Skip to main content
Equibles

PLATINUM INVESTMENT MANAGEMENT LTD

Position in AURA — Aura Biosciences, Inc.

CIK 1256071 SYDNEY AUSTRALIA 2000, C3
Back to AURA Full portfolio

Position in AURA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$794,241
+$45,865 QoQ
Shares Held
111,865
0.0% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#50
of 146 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AURA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. AURA ranks #22 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 58,314 $7,740,017
2 COGT
Cogent Biosciences, Inc.
 154,220 $5,968,314
3 IMVT
Immunovant, Inc.
 144,671 $5,574,173
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 64,752 $5,277,935
5 IDYA
IDEAYA Biosciences, Inc.
 138,708 $5,169,647
6 VERA
Vera Therapeutics, Inc.
 113,687 $4,878,309
7 GPCR
Structure Therapeutics Inc.
 90,363 $4,849,782
8 RCUS
Arcus Biosciences, Inc.
 134,217 $4,137,910

All Filings in AURA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $794,241 111,865
2026-03-31 $748,376 111,865
2025-12-31 $609,664 111,865
2025-09-30 $836,784 135,402
2025-06-30 $847,616 135,402
2025-03-31 $951,417 162,358
2024-12-31 $1,334,582 162,358
2024-09-30 $1,446,609 162,358
2024-06-30 $1,227,426 162,358
2024-03-31 $1,414,138 180,145
2023-12-31 $1,596,084 180,145